Overview
Disorders of the carnitine cycle and carnitine transport are a group of rare inherited metabolic conditions that affect how the body uses fats for energy. Carnitine is a natural substance that acts like a shuttle, carrying fatty acids into the powerhouses of cells (called mitochondria) so they can be burned for fuel. When any step in this process is broken — whether it is the transport of carnitine into cells or the cycle that moves fats across the mitochondrial membrane — the body cannot properly convert fat into energy. This group includes several specific conditions such as Primary Carnitine Deficiency (also called Carnitine Uptake Defect or OCTN2 deficiency), Carnitine Palmitoyltransferase I deficiency (CPT1), Carnitine Palmitoyltransferase II deficiency (CPT2), Carnitine-Acylcarnitine Translocase deficiency (CACT), and others. Symptoms can vary widely depending on which specific disorder a person has, but commonly include muscle weakness, heart problems, low blood sugar, and liver enlargement. Some forms are life-threatening in infancy, while others may not appear until adulthood. Many affected individuals are identified through newborn screening programs before symptoms develop. Treatment typically involves dietary changes, avoiding fasting, and in some forms, carnitine supplementation. With early diagnosis and proper management, many patients can live relatively normal lives, though ongoing medical care is essential.
Key symptoms:
Muscle weakness or pain, especially during exercise or illnessDangerously low blood sugar (hypoglycemia), especially when fastingEnlarged liver (hepatomegaly)Heart muscle disease (cardiomyopathy) or irregular heartbeatExtreme tiredness and low energyMuscle breakdown (rhabdomyolysis) triggered by exercise or feverPoor feeding and failure to thrive in infantsVomiting and irritability in babiesSeizures due to low blood sugarDevelopmental delays in some childrenFainting or sudden collapseDark or cola-colored urine after muscle breakdown
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Disorder of carnitine cycle and carnitine transport.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Disorder of carnitine cycle and carnitine transport at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Disorder of carnitine cycle and carnitine transport.
Community
No community posts yet. Be the first to share your experience with Disorder of carnitine cycle and carnitine transport.
Start the conversation →Latest news about Disorder of carnitine cycle and carnitine transport
No recent news articles for Disorder of carnitine cycle and carnitine transport.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific disorder within the carnitine cycle group does my child or I have, and what does that mean for treatment?,Do I or my child need to take L-carnitine supplements, and if so, what dose and how often?,What should I do if my child gets sick and cannot eat — when should I go to the emergency room?,Are there specific foods or activities we need to avoid, and what does a safe diet look like day to day?,Should other family members be tested for this condition?,How often do we need follow-up appointments, and which specialists should be on our care team?,Is there a written emergency protocol I can share with the school, emergency room, and other caregivers?
Common questions about Disorder of carnitine cycle and carnitine transport
What is Disorder of carnitine cycle and carnitine transport?
Disorders of the carnitine cycle and carnitine transport are a group of rare inherited metabolic conditions that affect how the body uses fats for energy. Carnitine is a natural substance that acts like a shuttle, carrying fatty acids into the powerhouses of cells (called mitochondria) so they can be burned for fuel. When any step in this process is broken — whether it is the transport of carnitine into cells or the cycle that moves fats across the mitochondrial membrane — the body cannot properly convert fat into energy. This group includes several specific conditions such as Primary Carnitin
How is Disorder of carnitine cycle and carnitine transport inherited?
Disorder of carnitine cycle and carnitine transport follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Disorder of carnitine cycle and carnitine transport?
1 specialists and care centers treating Disorder of carnitine cycle and carnitine transport are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.